FIS
51
-4
AMAT
33
-13
GOOG
57
-6
HSIC
45
5
OI
42
-3
REGN
38
-2
STZ
52
-6
AME
74
-4
ABT
59
2
ETR
65
2
DRI
50
-3
RCL
83
-2
DVN
14
-6
PCAR
56
-5
DIS
85
3
AA
56
15
AEP
54
6
JNPR
50
-6
CB
57
2
AMGN
42
-4
FIS
51
-4
AMAT
33
-13
GOOG
57
-6
HSIC
45
5
OI
42
-3
REGN
38
-2
STZ
52
-6
AME
74
-4
ABT
59
2
ETR
65
2
DRI
50
-3
RCL
83
-2
DVN
14
-6
PCAR
56
-5
DIS
85
3
AA
56
15
AEP
54
6
JNPR
50
-6
CB
57
2
AMGN
42
-4
Financhill
Back

Shoals Technologies Group Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
4

SHLS
Shoals Technologies Group

Last Price:
4.57
Seasonality Move:
-8.23%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
4
Shoals Technologies Group (SHLS) is a Sell

Is Shoals Technologies Group a Buy, Sell or Hold?

  • The current Shoals Technologies Group [SHLS] share price is $4.56. The Score for SHLS is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • SHLS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SHLS Stock Price Chart

What is Shoals Technologies Group's stock price today?

  • The Shoals Technologies Group share price today is $4.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SHLS is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SHLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37 Sell
Chaikin Money Flow: -6101646 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.94 - 5.68) Sell
Bollinger Bands (100): (5.17 - 6.35) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SHLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.33 Sell
20-day SMA: 5.34 Sell
50-day SMA: 5.55 Sell
200-day SMA: 8.05 Sell
8-day EMA: 5.17 Sell
20-day EMA: 5.33 Sell
50-day EMA: 5.5 Sell
200-day EMA: 8.24 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Shoals Technologies Group Earnings Growth & SHLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.08 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Shoals Technologies Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):